Add to ORKGThe author discusses the impact of the European Union's Directive for the legal protection of biotechnological inventions (Directive 98/44/EC of 6 July 1998. Specific attention is given to the absence from provisions of the mention of human stem cells, which generated significant ethical and legal debate in the UK, and globally, at that time. The paper considers the robustness of European patent provisions, and focusses on the potential consequences in the continuing debate of human stem cells
The European Parliament rejected in 1995 the European Commission proposal to harmo-nize legal protec...
PhDIn 2013, the US Supreme Court declared isolated gene sequences as ‘products of nature’ and hence,...
Abstract: This thesis investigates the patentability of human embryonic stem cells in Europe and the...
The article highlights some issues raised by the recent decision of the Court of Justice of European...
Stem cells are the first type of cells developed in an embryo. They have the ability to divide, self...
The original justification for Directive 98/44/EC of the European Parliament and of the Council of 6...
This article considers the integral role played by patent law in respect of stem cell research. It h...
Significant differences prevail in human Stem Cell Research (hSCR) policy and patent protection of h...
Humans in the era of 21st century have witnessed development at its epitome, coupled with obvious pr...
On 18 December 2014, in International Stem Cell Corporation v. Comptroller General of Patents, Desig...
Austin Smith and others argue in favour of patenting technologies derived from human embryonic stem ...
Stem cell and biotechnological research is a flourishing industry around the globe. The growth of th...
Advances in stem cell biology have raised legal challenges to the patentability of stem cells and an...
The topic of this book is one of the most contentious, complex and at the same time very important i...
73-75As a European intellectual property lawyer, the author is often struck by the amount of compar...
The European Parliament rejected in 1995 the European Commission proposal to harmo-nize legal protec...
PhDIn 2013, the US Supreme Court declared isolated gene sequences as ‘products of nature’ and hence,...
Abstract: This thesis investigates the patentability of human embryonic stem cells in Europe and the...
The article highlights some issues raised by the recent decision of the Court of Justice of European...
Stem cells are the first type of cells developed in an embryo. They have the ability to divide, self...
The original justification for Directive 98/44/EC of the European Parliament and of the Council of 6...
This article considers the integral role played by patent law in respect of stem cell research. It h...
Significant differences prevail in human Stem Cell Research (hSCR) policy and patent protection of h...
Humans in the era of 21st century have witnessed development at its epitome, coupled with obvious pr...
On 18 December 2014, in International Stem Cell Corporation v. Comptroller General of Patents, Desig...
Austin Smith and others argue in favour of patenting technologies derived from human embryonic stem ...
Stem cell and biotechnological research is a flourishing industry around the globe. The growth of th...
Advances in stem cell biology have raised legal challenges to the patentability of stem cells and an...
The topic of this book is one of the most contentious, complex and at the same time very important i...
73-75As a European intellectual property lawyer, the author is often struck by the amount of compar...
The European Parliament rejected in 1995 the European Commission proposal to harmo-nize legal protec...
PhDIn 2013, the US Supreme Court declared isolated gene sequences as ‘products of nature’ and hence,...
Abstract: This thesis investigates the patentability of human embryonic stem cells in Europe and the...